A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07308704
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Transthoracic Echocardiography (TTE) — DIAGNOSTIC_TEST
    AI analysis of transthoracic echocardiography to improve disease detection.

Study Details

The purpose of this study is to deploy and evaluate informational AI-Echo algorithms that assist echo clinicians in interpreting core echocardiographic parameters (e.g., LV/RV size and function, valvular disease severity) and stratifying disease progression risk. The primary outcome is clinician usability, interpretive consistency, and workflow integration. Second, we will conduct a pragmatic, stepped-wedge clinical trial with multiple arms evaluating diagnostic AI-Echo algorithms designed to identify specific cardiovascular diseases- such as genetic cardiomyopathy, ischemic heart disease, and cardiac amyloidosis-and assess whether AI deployment increases diagnostic testing and shortens time to diagnosis. Trials will be conducted using EHR-based notification systems with cluster-level randomization.

Key Dates

Start date
Feb 26, 2026
Status verified
Apr 2026
Primary completion
Feb 29, 2028
Completion
Feb 29, 2028

Study Design

Enrollment
10,040,000 participants (estimated)

Arms

  • Arm: Genetic cardiomyopathy arm
  • Arm: Ischemic cardiomyopathy arm
  • Arm: Cardiac amyloidosis arm
  • Arm: Hypertrophic cardiomyopathy (HCM) arm

Primary Outcome Measure

Number of patients diagnosed with genetic cardiomyopathy confirmed by genetic testing [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Tim Poterucha, M.D.
507-284-2129
Tim Poterucha, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

Related Studies